会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 74. 发明授权
    • Polymeric drug formulations
    • 聚合药物制剂
    • US07005454B2
    • 2006-02-28
    • US09257145
    • 1999-02-24
    • Stephen BrocchiniStephen R. HansonJoachim B. Kohn
    • Stephen BrocchiniStephen R. HansonJoachim B. Kohn
    • A61K47/30A61K47/32A61K47/34
    • A61K9/146A61K9/2031A61K9/204A61K9/7007
    • Polymeric drug formulations containing a non-releasing single-phase dispersion of a water-soluble drug in a water-insoluble tissue-compatible polymer matrix. Polymeric drug formulations are also disclosed containing a single-phase dispersion of a water-soluble drug and a water-insoluble tissue-compatible polymer matrix, and a second, phase-disrupting polymer that is non-miscible with the tissue-compatible polymer and is present in an amount sufficient to form phase-separated microdomains of the second polymer in the tissue-compatible polymer matrix, so that the release rate of the water-soluble drug from the tissue-compatible polymer matrix is related to the amount of the second polymer. Methods of preparing the polymeric drug formulations are also described, as well as methods for site-specific drug delivery utilizing the polymeric drug formulations.
    • 含水溶性药物的非释放单相分散体在水不溶性组织相容的聚合物基质中的聚合药物制剂。 还公开了含有水溶性药物和水不溶性组织相容聚合物基质的单相分散体的聚合药物制剂,以及与组织相容的聚合物不可混溶的第二种相位破坏性聚合物,并且是 存在的量足以在组织相容性聚合物基质中形成第二聚合物的相分离微区,使得来自组织相容性聚合物基质的水溶性药物的释放速率与第二聚合物的量相关 。 还描述了制备聚合物药物制剂的方法,以及利用聚合物药物制剂的用于位点特异性药物递送的方法。